We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
A Quick Look at Standard Treatments for Sickle Cell Disease
Biree Andemariam, MD
Caroline Freiermuth, MD
Why Do We Need New Therapies for Sickle Cell Disease?
Making the Transition: Managing Patients with Sickle Cell Disease Across the Lifespan
Improving Communication Across Care Settings
Diverse Manifestations of Sickle Cell Disease
Preventative Management of Sickle Cell Disease Complications
Cell and Gene Therapies for Sickle Cell Disease
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Emergency Medicine Module
James Galvin, MD, MPH, FANA
Gloria Chiang, MD
Christopher Carpenter, MD, MSC, FACEP, FAAEM, AGSF
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Closing Module
Charles P. Vega, MD
Case Presentation: Management of ICH in the Anticoagulated Patient Using Specific Reversal Therapy: Importance of Timing
Adrian R. Parry-Jones, FRCP, PhD
Real World Data and the Management of Intracranial Hemorrhages (ICH) in Anticoagulated Patients
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
David Seiffge, MD
Case Presentation: Management of a Patient With Factor Xa-Associated ICH Using Specific Reversal Therapy
Development of a Care Pathway Using Specific Reversal Agents for Anticoagulated Patients With ICH
Case Presentation: Management of a Patient With Vitamin K Antagonist-Associated Intracranial Hemorrhage (ICH)
Repletion Management for Vitamin K Antagonist Anticoagulation
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education